Esketamine

Generic Name
Esketamine
Brand Names
Spravato
Drug Type
Small Molecule
Chemical Formula
C13H16ClNO
CAS Number
33643-46-8
Unique Ingredient Identifier
50LFG02TXD
Background

Major depressive disorder (MDD) is a significant cause of disability worldwide and the most common illness preceding suicide. On March 5, 2019, the nasal spray drug, esketamine, also known as Spravato (by Janssen Pharmaceuticals), was approved by the FDA for treatment-resistant major depression.
...

Indication

Esketamine is indicated in combination with an oral antidepressant for the treatment of treatment-resistant depression in adults. It is also indicated for the treatment of depressive symptoms in adults with major depressive disorder experiencing acute suicidal ideation or behaviour.

Associated Conditions
Major Depressive Disorder (MDD), Major depressive disorder, recurrent episode, Pain
Associated Therapies
Intubation

Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia and Long-term Outcomes

First Posted Date
2023-02-08
Last Posted Date
2023-02-09
Lead Sponsor
Peking University First Hospital
Target Recruit Count
199
Registration Number
NCT05718544
Locations
🇨🇳

Peking University First Hospital, Beijing, Beijing, China

Effect of Subanesthetic Dose of Esketamine on Sleep Quality and Recovery of Gastrointestinal Function in Patients Undergoing General Anesthesia Laparoscopic Uterine Surgery in the Early Postoperative Period

First Posted Date
2023-02-08
Last Posted Date
2024-05-21
Lead Sponsor
Zhuan Zhang
Target Recruit Count
138
Registration Number
NCT05715671
Locations
🇨🇳

the Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, China

Effect of Low-dose Esketamine on Maternal Depression at 3 Years After Childbirth

Phase 4
Active, not recruiting
Conditions
Interventions
First Posted Date
2023-01-26
Last Posted Date
2024-12-05
Lead Sponsor
Peking University First Hospital
Target Recruit Count
364
Registration Number
NCT05698394
Locations
🇨🇳

Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

🇨🇳

Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, China

🇨🇳

Women's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

and more 1 locations

Remiazolam Combined With Esketamine in Painless Bidirectional Endoscopy in Children

First Posted Date
2023-01-17
Last Posted Date
2023-08-21
Lead Sponsor
Tongji Hospital
Target Recruit Count
106
Registration Number
NCT05686863
Locations
🇨🇳

Tongji Hospital, Wuhan, Hubei, China

Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma

First Posted Date
2023-01-04
Last Posted Date
2023-03-29
Lead Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Target Recruit Count
60
Registration Number
NCT05670561
Locations
🇨🇳

The Second Affiliated Hospital, Chongqing Medical University, Chongqing, Chongqing, China

Remimazolam Versus Propofol for Painless Abortion

First Posted Date
2022-12-02
Last Posted Date
2022-12-02
Lead Sponsor
Maternal and Child Health Hospital of Hubei Province
Target Recruit Count
100
Registration Number
NCT05635955
Locations
🇨🇳

Maternal and Child Health Hospital of Hubei Province, Wuhan, Hubei, China

KetaMoHydBup: Pharmacokinetic Interaction of S-ketamine, Morphine, Hydromorphone and Buprenorphine

First Posted Date
2022-10-07
Last Posted Date
2022-10-07
Lead Sponsor
Elina Brinck
Target Recruit Count
12
Registration Number
NCT05571176

VA Aripiprazole vs Esketamine for Treatment Resistant Depression

First Posted Date
2022-09-26
Last Posted Date
2024-01-05
Lead Sponsor
VA Office of Research and Development
Registration Number
NCT05554627
Locations
🇺🇸

Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR, Little Rock, Arkansas, United States

🇺🇸

New Mexico VA Health Care System, Albuquerque, NM, Albuquerque, New Mexico, United States

🇺🇸

Edward Hines Jr. VA Hospital, Hines, IL, Hines, Illinois, United States

and more 23 locations

The Effects of Intraoperative Esketamine on Postoperative Pain and Mood in Patients With Inflammatory Bowel Disease

First Posted Date
2022-08-18
Last Posted Date
2023-04-04
Lead Sponsor
Jinling Hospital, China
Target Recruit Count
120
Registration Number
NCT05506787
Locations
🇨🇳

Anesthesiology Department, Jinling Hospital Affiliated to Nanjing University, Nanjing, Jiangsu, China

© Copyright 2024. All Rights Reserved by MedPath